The Northeast Ohio Multipurpose Arthritis and Musculoskeletal Diseases Center (NEOMAMDC) programs are designed to meet the arthritis needs of a target population numbering over 4 million people in Northeast Ohio (40% of the State of Ohio population). NEOMAMDC represents a coordinated joint endeavor by members of the two Rheumatic Disease Units located at University Hospital (UH)/Case Western Reserve University (CWRU) and MetroHealth Medical Center (MHMC)/CWRU in conjunction with the Department of Orthopaedics/CWRU and with the Skeletal Research Center in the Department of Biology/CWRU. Activities of the Center represent a diverse mix of research, education and community/epidemiology/health services research programs both specifically funded by the Center, and programs funded from an array of other sources. The long-term objectives of this proposal, as before, are directed toward expansion of basic research and education/epidemiology/health services research initiatives. new proposed studies include Developmental & Feasibility (D&F) projects directed toward studies of: Link Protein PTR Domain Structure by NMR, Function of the CD6 T-Lymphocyte Co-Stimulatory Molecule in Immune Development and in Autoimmune Disease. Health Services Research projects proposed include (1) Cleveland-Florida Buffers of Arthritis-Disability Cascade Study; (2) Osteoporosis Prevention in Pre-Adolescent Girls (Be a Star, Bank on Your Bones); Core Programs include a Molecular Biology cDNA Sequencing Core and a Immunohistochemistry Core. Administration includes Administrative Policy, Executive, Operations (Steering) and Community Advisory Committees to fully interdigitate Center/University/Community interface.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Comprehensive Center (P60)
Project #
2P60AR020618-20
Application #
2677291
Study Section
Special Emphasis Panel (ZAR1-AAA-C (M1))
Project Start
1978-12-01
Project End
2002-06-30
Budget Start
1998-09-15
Budget End
1999-06-30
Support Year
20
Fiscal Year
1998
Total Cost
Indirect Cost
Name
Case Western Reserve University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
077758407
City
Cleveland
State
OH
Country
United States
Zip Code
44106
Miwa, Hazuki E; Gerken, Thomas A; Huynh, Tru D et al. (2009) Conserved sequence in the aggrecan interglobular domain modulates cleavage by ADAMTS-4 and ADAMTS-5. Biochim Biophys Acta 1790:161-72
Atif, U; Philip, A; Aponte, J et al. (2008) Absence of association of asporin polymorphisms and osteoarthritis susceptibility in US Caucasians. Osteoarthritis Cartilage 16:1174-7
Kraus, V B; Jordan, J M; Doherty, M et al. (2007) The Genetics of Generalized Osteoarthritis (GOGO) study: study design and evaluation of osteoarthritis phenotypes. Osteoarthritis Cartilage 15:120-7
Miwa, Hazuki E; Gerken, Thomas A; Huynh, Tru D et al. (2006) Mammalian expression of full-length bovine aggrecan and link protein: formation of recombinant proteoglycan aggregates and analysis of proteolytic cleavage by ADAMTS-4 and MMP-13. Biochim Biophys Acta 1760:472-86
Holderbaum, D; Malvitz, T; Ciesielski, C J et al. (2005) A newly described hereditary cartilage debonding syndrome. Arthritis Rheum 52:3300-4
Denko, Charles W; Malemud, Charles J (2005) Role of the growth hormone/insulin-like growth factor-1 paracrine axis in rheumatic diseases. Semin Arthritis Rheum 35:24-34
Ievers-Landis, Carolyn E; Burant, Christopher; Drotar, Dennis et al. (2005) A randomized controlled trial for the primary prevention of osteoporosis among preadolescent girl scouts: 1-year outcomes of a behavioral program. J Pediatr Psychol 30:155-65
Vashishth, D (2005) Collagen glycation and its role in fracture properties of bone. J Musculoskelet Neuronal Interact 5:316
Denko, Charles W; Malemud, Charles J (2005) Serum growth hormone and insulin but not insulin-like growth factor-1 levels are elevated in patients with fibromyalgia syndrome. Rheumatol Int 25:146-51
Denko, Charles W; Malemud, Charles J (2004) Age-related changes in serum growth hormone, insulin-like growth factor-1 and somatostatin in system lupus erythematosus. BMC Musculoskelet Disord 5:37

Showing the most recent 10 out of 92 publications